Trump Signs Law to Launch Dollar 2.0
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
| Open | 195.93 | Prev Close | 195.93 |
| High | 196.03 | Low | 195.50 |
| Volume | 808 | Volume (Avg) | 8,286 |
| 52 Week High | 197.18 | 52 Week Low | 137.37 |
| Market Cap | 471.5B | PE Ratio | 18.89 |
General
| Name | Johnson & Johnson |
| Ticker | JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 138,100 |
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Highlights
| Analyst Target | 206.45 |
| Market Cap | 471,547,200,000 |
| PE Ratio | 18.89 |
| PEG Ratio | 1.06 |
| EBITDA | 31,921,999,872 |
Valuation
| Trailing PE | 18.93 |
| Forward PE | 17.04 |
| Price/Sales (Trailing 12 Mt.) | 5.12 |
| Price/Book (Most Recent Quarter) | 5.95 |
Technicals
| Beta | 0.35 |
| 52 Week High | 197.18 |
| 52 Week Low | 137.37 |
| 50 Day Average | 5.12% |
| 200 Day Average | 17.16% |
Dividend
Johnson & Johnson pays out a dividend of $5.19 per share, with a dividend yield of 2.65%.
JNJ's next dividend payment will be made to shareholders on December 9, 2025.
They pay out 84.80% of their earnings out as a dividend.
Recent Dividends
| Dec 9, 2025 | $1.30 |
| Sep 9, 2025 | $1.30 |
| Jun 10, 2025 | $1.30 |
| Mar 4, 2025 | $1.24 |
| Dec 10, 2024 | $1.24 |
| Sep 10, 2024 | $1.24 |
| Jun 4, 2024 | $1.24 |
| Mar 5, 2024 | $1.19 |
| Dec 5, 2023 | $1.19 |
This Inexpensive Tesla Rival Is Quietly Gaining Ground — Key Ranking Suggests A Major Breakout Could Be Imminent
Li Auto surges into the top 10th percentile value ranking, up 1.30 points. Undervalued Tesla rival with moderate growth.
Trump White House Clamps Down on Press Access
White House restricts reporter access to West Wing Room 140; NSC cites sensitive material, echoing Pentagon curbs, raising press concerns.
Metals... Not Missles... Is the New Arms Race - Ad
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
Billie Eilish Asks Zuckerbeg, Other Billionaires To Donate
Billie Eilish urges billionaires to share their wealth for good causes during award acceptance speech. Mark Zuckerberg in attendance.
Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock
Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday
Key stocks to watch include Williams Companies, Spirit AeroSystems, Goodyear Tire & Rubber, IDEXX Laboratories, and ON Semiconductor
Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'
President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Nation's largest fleet of police Cybertrucks to patrol Las Vegas
LAS VEGAS (AP) — The nation's largest police fleet of Tesla Cybertrucks is set to begin patrolling the streets of Las Vegas in November thanks to a donation from a U.S. tech billionaire, raising concerns about the blurring of lines between public and private interests.
Bill.Com Scales Payments Footprint With 33 Million Transactions
Bill Holdings, Inc. (BILL) reports Q1 fiscal 2026 results, beating analyst estimates with adjusted EPS of 61c and revenue of $395.74M.
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low
Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.
OpenAI and Amazon sign $38B deal for AI computing power
SEATTLE (AP) — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial intelligence systems on Amazon's cloud computing services.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Bill Ackman's Hertz Stake Is Starting To Look Like His Next Chipotle Moment
Bill Ackman's investment in Hertz may be the next Chipotle moment as the rental-car company sees a surprise profit and a 40% stock surge.
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.
Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad
Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!
Bitcoin, Ethereum, XRP, Dogecoin Fall As 'Fear' Sentiment Persists: Analyst Says BTC Will Be In 'Good Territory' For New High In November If...
Leading cryptocurrencies dive while stock futures rose on Sunday, in the wake of the U.S.-China trade truce.
S&P Global Boosts Outlook As CEO Hails Exceptional Growth
S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Japanese game maker Nintendo reports zooming sales and profit on its hit Switch 2 machine
TOKYO (AP) — Japanese video-game maker Nintendo’s net profit jumped 85% in April-September from the year before, as its sales more than doubled following the launch of its hit Switch 2 console in June, the company said Tuesday.
Hillary Clinton Says Trump Taking A 'Break' From Gold-And-Marble Interior Renovations To Defy Court Order On SNAP: 'Nero Would Be Proud'
Hillary Clinton criticizes Trump for withholding SNAP benefits during shutdown, accusing him of defying court order and being indifferent to public suffering. Democrats blast Trump for creating hunger crisis and breaking the law.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Zohran Mamdani Was Crypto Bettors' Overwhelming Favorite For New York City Mayor At 100% Odds — And He Just Won
Zohran Mamdani won the high-stakes New York City mayoral race Tuesday, a victory widely anticipated by cryptocurrency bettors, who had overwhelmingly backed the Democratic Socialist.
Japan's Toyota, hurt by President Trump's tariffs, reports a drop in profit
TOKYO (AP) — Toyota reported a 7% year-on-year drop in its profit for April-September on Wednesday, as President Donald Trump’s tariffs slammed Japanese automakers, but it raised its forecast for the full fiscal year.
Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad
E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.
As Government Shutdown Enters 33rd Day, NYC Officials Warn Of Potential Delays, Ground Stoppage At Newark Airport
NYC officials warn of staffing shortages at Newark airport due to government shutdown, causing delays & potential ground stop.
Benzinga Bulls And Bears: Starbucks, DraftKings, Enovix — And AI Stocks Take A Fall
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Taylor Swift, Elon Musk, Donald Trump, MrBeast — Robinhood Just Made Their Mojo Tradable
Robinhood has new prediction markets for its customers, with a focus on the entertainment sector. Here are some of the new markets.
'No hire' job market leaves unemployed in limbo as threats to economy multiply
WASHINGTON (AP) — When Carly Kaprive left a job in Kansas City and moved to Chicago a year ago, she figured it would take three to six months to find a new position. After all, the 32-year old project manager had never been unemployed for longer than three months.
Metals... Not Missles... Is the New Arms Race - Ad
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
Peloton Stock Rallies After Q1 Earnings: Here's Why
Peloton stock climbs after the company released its first-quarter earnings report after Thursday's closing bell.
Abu Dhabi hosts oil summit as OPEC+ halts production hikes planned for first quarter of 2026
ABU DHABI, United Arab Emirates (AP) — Abu Dhabi hosted a major oil summit Monday, hours after the OPEC+ cartel and its allies said it would halt further production increases planned in the first quarter of 2026 over concerns of too much supply in the market.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
Court Blocks Trump's SNAP Reductions, But Stricter Eligibility Rules Begin
New work requirements for SNAP begin Saturday, but benefits may not be issued through November due to the government shutdown.
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.